Navigation Links
Kosan Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Epothilone KOS-1584 at ASCO

HAYWARD, Calif., June 04, 2007 /PRNewswire-FirstCall/ -- Kosan Biosciences Incorporated presented data from a Phase 1 clinical trial showing that KOS-1584/R1645, an epothilone under co-development with Roche, demonstrated promising antitumor activity and tolerability in patients with solid tumors. KOS-1584/R1645 showed activity in 32% of patients (13 of 41 evaluable) including activity in patients with non-small cell lung, ovarian, breast, prostate, head and neck and other cancers. Common toxicities were generally low-grade and manageable. Data from this ongoing trial were presented on Sunday, June 3, 2007, in a poster titled, "Phase 1 Trial of KOS-1584 (a Novel Epothilone) Using Two Weekly Dosing Schedules," by Howard Burris, M.D., Sarah Cannon Research Institute, Nashville, TN, at the 2007 Annual Meeting of the American Society of Clinical Oncology (ASCO).

"Epothilones are promising anticancer agents due to their taxane-like mechanism of action and demonstrated activity in taxane resistant tumors," said Dr. Burris. "Kosan's novel epothilone is of particular interest due to its level of antitumor activity in patients with highly refractory disease and manageable side effect profile. This promising compound warrants continued development."

"KOS-1584/R1645 is a highly potent compound with attractive pharmaceutical properties, including a long half-life, large volume of distribution, wide therapeutic index and ease of formulation that has demonstrated encouraging activity in Phase 1 trials," said Robert G. Johnson, Jr., M.D., Ph.D., Kosan's President and Chief Executive Officer. "We believe that KOS-1584/R1645, based on our novel epothilone D backbone, has the potential to be superior to other epothilones currently in development and ultimately emerge as a meaningful competitor in the taxane market. We look forward to initiating a robust Phase 2 clinical program, with the support of our partner Roch
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90 Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory Breast and Ovarian Cancers at ASCO
2. Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing Promising Antitumor Activity in Multiple Myeloma at ASCO
3. Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO
4. Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR
5. Kosan Presents Preclinical Antitumor and Safety Data On Next-Generation Epothilone KOS-1803 at AACR
6. Kosan Presents Data on Cardiac Safety Profile of Hsp90 Inhibitor Tanespimycin (KOS-953) at AACR
7. Kosan Announces Data Presentations at Upcoming AACR Annual Meeting
8. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
9. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
10. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
11. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
Post Your Comments:
(Date:3/1/2015)... , March 1, 2015  Patients suffering from ... against this debilitating foot ailment, according to research ... ,s Annual Scientific Meeting . Researchers utilized ... emulsify and remove diseased fasciitis tissue. Permanently removing ... to regrow in its place, restoring normal function. ...
(Date:2/27/2015)... WuXi PharmaTech (Cayman) Inc. (NYSE:  WX), a ... the pharmaceutical, biotechnology, and medical device industries with operations ... the United States , congratulates our partner TaiMed ... FDA for ibalizumab (TMB355). The FDA designates a drug ... or in combination with one or more other drugs, ...
(Date:2/27/2015)... Israele, February 27, 2015 ... sviluppo dell,innovativo sistema di monitoraggio dell,infarto congestizio (CHF ... sull,uomo-     ... di nuovo sistema per il monitoraggio cardiaco destinato ... annunciato oggi di aver concluso una raccolta di ...
Breaking Medicine Technology:Interventional radiology treatment relieves chronic plantar fasciitis 2Interventional radiology treatment relieves chronic plantar fasciitis 3WuXi Congratulates TaiMed Biologics on Receiving Breakthrough Therapy Designation from U.S. FDA 2Vectorious Medical Technologies completa una raccolta di 5 milioni di dollari 2
... IRVINE, Calif., Sept. 28 Cobalis Corp. (Pink ... Update Conference Call to provide investors and shareholders with further ... securities, financial and legal issues. Shareholders and investors ... held Tuesday, October 5, 2010 at 1:15pm Pacific Time. Interested ...
... Sept. 28 Grammy Award winner Gloria Gaynor -- whose ... -- will appear at AARP,s Orlando@50+ National Event & ... her own experience with this potentially debilitating condition. This high ... place September 30-October 2 at the Orange County ...
Cached Medicine Technology:Cobalis Corp. Announces Second Update Conference Call for Investors on October 5, 2010 2Gloria Gaynor to Appear at AARP's Orlando@50+ National Event & Expo 2
(Date:3/1/2015)... “ The Barrel Mill ” was featured on NewsWatch ... look at the latest and coolest technology products and services ... a technology expert, conducted the review and shared with viewers ... According to Home Distillation of Alcohol, it's understood that oak ... pretty cool product that’ll help anyone achieve a barrel aged ...
(Date:3/1/2015)... February 28, 2015 CrossFit Attollo is a ... are offering a special discount to new members. Now ... for a three month contract will receive their fourth month ... would cost members $440. The three month contract is ... and then the fourth month comes in at only $55. ...
(Date:2/28/2015)... In recent years Medical Marijuana has continuously ... as a way for them to expand their patient base ... medicine. Since the FDA still lists Cannabis as a Schedule ... licensed physicians that can help guide them when recommending ... in Santa Cruz, CA is a leader in the ...
(Date:2/28/2015)... February 28, 2015 In a recent ... of Game Change Athlete Development Services ... about the benefits of athlete development and player engagement ... the unique challenges that athletes face and how off-field ... success. , Fletcher became involved in athlete development issues ...
(Date:2/28/2015)... 2015 With their commitment to achieving ... an additional exercise to their already robust library of ... most commonly known as, is often performed on a ... executed in a relatively safe manner and can be ... The full description of “Rope Pulls” is located in ...
Breaking Medicine News(10 mins):Health News:An Oak Infusion Spiral was Featured on NewsWatch Television on January 30, 2015 2Health News:CrossFit Gym in Vancouver WA Offers Spring Special 2Health News:Reputable Cannabis Doctor In Santa Cruz and Monterey Joins the Medical Cannabis Network 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 3
... law suit filed against sunscreen manufacturers in California as they ... on the other hand still recommend the liberal use of ... (SPF) ratings nor the label on the products gives a ... not cause burning but do cause aging of the skin ...
... of marriages. // ,Pathology labs in the city have registered ... season. ,Rajesh Bose (name changed) got an HIV test ... But her parents thought I was a flirt," said Bose. "But when ... ,Not only men but prospective brides too are going in ...
... Roseborough et al., mitochondrial K-ATP channel opener, diazoxide, prevents ... are the common problems that occur during aortic surgery ... in neurological deficits. But the works of Roseborough et ... injuries. , The results of his work ...
... protein present in chronic inflammatory conditions called heat shock ... – which is associated with the immune responses, a ... ,The specific response has earlier been observed in juvenile ... the role of HSP60 in inflammatory myositis. Inflammatory myositis ...
... club, for people living with HIV/Aids, started by Luta Shaba, an ... country. // ,Shaba says she dreams of ... use recommended safe sex methods. She says many of her ... large social stigma attached to HIV/Aids. Her club is a huge ...
... a coordinated action plan to check the deteriorating sexual ... ,The plan by UN agencies, WHO and UN Population ... more than half a million women die during pregnancy ... annually. , ,"There is a really worrying rise ...
Cached Medicine News:Health News:New Way To Combat Spinal Cord Injury during Aortic Surgery 2Health News:Proteins – A New Way to Treat Children's Muscle Diseas 2
... best lens available for ... One 62 mirror. Tilted ... and laser beam astigmatism. ... used on most patients ...
Mcintyre straight lachrymal cannula, closed end, two side ports at 0.3 mm, straight shaft....
Lachrymal cannula, straight....
The first easy-to use peroxide system offers proven efficacy that's pure and simple. The convenience of a multi-purpose cleaner/rinse in one bottle. Added power of peroxide in the other bottle....
Medicine Products: